Abstract
We evaluated the effect of adding secondary cytoreductive surgery to postoperative chemotherapy on progression-free survival and overall survival among patients who had advanced ovarian cancer and residual tumor exceeding 1 cm in diameter after primary surgery.
Cite
CITATION STYLE
APA
Rose, P. G., Nerenstone, S., Brady, M. F., Clarke-Pearson, D., Olt, G., Rubin, S. C., … Small, J. M. (2004). Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma. New England Journal of Medicine, 351(24), 2489–2497. https://doi.org/10.1056/nejmoa041125
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free